Furthermore, AnaAspClop-treated MCF7 cells displayed evidence of a partial EMT, whereas AnaAspClop-treated T47D cells showed a trend towards the acquisition of mesenchymal markers (independent of TGFβ1) and could suggest a role for PAR1-mediated effects [34] and, furthermore, a more aggressive tumour profile in T47D cells [62]. This evidence concerns the gene TGFB1 and neoplasm.